Health Care & Life Sciences » Biotechnology | Enzo Biochem Inc.

Enzo Biochem Inc. | Income Statement

Fiscal year is August-July. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
93,707.00
95,947.00
97,599.00
102,773.00
107,804.00
104,713
Cost of Goods Sold (COGS) incl. D&A
54,835.00
54,268.00
54,772.00
57,190.00
59,478.00
60,385
Gross Income
38,872.00
41,679.00
42,827.00
45,583.00
48,326.00
44,328
SG&A Expense
57,852.00
54,959.00
55,491.00
55,830.00
49,713.00
51,365
EBIT
18,980.00
13,280.00
12,664.00
10,247.00
1,387.00
7,037
Unusual Expense
-
3,100.00
11,458.00
57,250.00
1,679.00
5,127
Non Operating Income/Expense
85.00
483.00
841.00
352.00
260.00
107
Interest Expense
54.00
208.00
245.00
136.00
-
-
Pretax Income
18,949.00
9,905.00
2,292.00
46,515.00
2,422.00
11,418
Income Tax
712.00
72.00
7.00
1,229.00
82.00
1,097
Consolidated Net Income
18,237.00
9,977.00
2,285.00
45,286.00
2,504.00
10,321
Net Income
18,237.00
9,977.00
2,285.00
45,286.00
2,504.00
10,321
Net Income After Extraordinaries
18,237.00
9,977.00
2,285.00
45,286.00
2,504.00
10,321
Net Income Available to Common
18,237.00
9,977.00
2,285.00
45,286.00
2,504.00
10,321
EPS (Basic)
0.46
0.23
0.05
0.97
0.05
0.22
Basic Shares Outstanding
39,607.00
42,561.00
45,355.00
46,153.00
46,350.00
46,972
EPS (Diluted)
0.46
0.23
0.05
0.97
0.05
0.22
Diluted Shares Outstanding
39,607.00
42,561.00
45,355.00
46,602.00
46,350.00
46,972
EBITDA
14,375.00
9,309.00
8,875.00
6,407.00
2,211.00
3,907
Non-Operating Interest Income
-
-
-
-
384.00
853

About Enzo Biochem

View Profile
Address
60 Executive Boulevard
New York New York 11735
United States
Employees -
Website http://www.enzo.com
Updated 07/08/2019
Enzo Biochem, Inc. engages in the research, development, and market of pharmaceutical products. Its medicines target the following conditions: inflammatory bowel disease, uveitis, human immunodeficiency virus, diabetes, and bone disorders. The company was founded by Elazar Rabbani, Barry W.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.